400 related articles for article (PubMed ID: 31405686)
1. Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.
Gómez AM; Henao DC; Taboada LB; Leguizamón G; Rondón MA; Muñoz OM; García-Jaramillo MA; León Vargas FM
Diabetes Metab Syndr; 2019; 13(4):2625-2631. PubMed ID: 31405686
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
[TBL] [Abstract][Full Text] [Related]
3. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
[TBL] [Abstract][Full Text] [Related]
5. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
Elbarbary NS
Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
Danne T; Kordonouri O; Holder M; Haberland H; Golembowski S; Remus K; Bläsig S; Wadien T; Zierow S; Hartmann R; Thomas A
Diabetes Technol Ther; 2011 Nov; 13(11):1129-34. PubMed ID: 21827318
[TBL] [Abstract][Full Text] [Related]
9. Effect of real-life insulin pump with predictive low-glucose management use for 3 months: Analysis of the patients treated in a Japanese center.
Tsunemi A; Sato J; Kurita M; Wakabayashi Y; Waseda N; Koshibu M; Shinohara M; Ozaki A; Nakamura H; Hirano N; Ikeda F; Satoh H; Watada H
J Diabetes Investig; 2020 Nov; 11(6):1564-1569. PubMed ID: 32374513
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with clinically significant hypoglycemia in patients with type 1 diabetes using sensor-augmented pump therapy with predictive low-glucose management: A multicentric study on iberoamerica.
Gómez AM; Imitola A; Henao D; García-Jaramillo M; Giménez M; Viñals C; Grassi B; Torres M; Zuluaga I; Muñoz OM; Rondón M; León-Vargas F; Conget I
Diabetes Metab Syndr; 2021; 15(1):267-272. PubMed ID: 33477103
[TBL] [Abstract][Full Text] [Related]
11. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
[TBL] [Abstract][Full Text] [Related]
12. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function.
Abraham MB; Nicholas JA; Ly TT; Roby HC; Paramalingam N; Fairchild J; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
BMJ Open; 2016 Apr; 6(4):e011589. PubMed ID: 27084290
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.
Abraham MB; Davey R; O'Grady MJ; Ly TT; Paramalingam N; Fournier PA; Roy A; Grosman B; Kurtz N; Fairchild JM; King BR; Ambler GR; Cameron F; Jones TW; Davis EA
Diabetes Technol Ther; 2016 Sep; 18(9):543-50. PubMed ID: 27505305
[TBL] [Abstract][Full Text] [Related]
15. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
16. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
[TBL] [Abstract][Full Text] [Related]
17. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
[TBL] [Abstract][Full Text] [Related]
18. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
20. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]